3D-MPLA-6A is the research-grade, hexa-acylated form of 3-O-desacyl-4'-monophosphoryl lipid A (MPLA), derived from the lipopolysaccharide (LPS) of Salmonella minnesota R595. Known for its highly characterized structure and strong biological activity, this molecule is widely recognized as the gold standard MPLA adjuvant for advanced immunology, vaccinology, and immunotherapy research. This product is a potent TLR4 agonist designed to support studies focused on innate immune activation, adjuvant development, immune signaling pathways, and formulation optimization. Its hexa-acyl architecture provides the molecular framework associated with robust receptor engagement and reproducible immune-stimulatory behavior, making it valuable in preclinical research, vaccine adjuvant screening, and mechanistic studies of host immune response. Because 3D-MPLA-6A is derived from a well-studied bacterial source and represents one of the most extensively characterized members of the MPLA family, it is highly relevant for researchers seeking a dependable reference compound for TLR4-mediated signaling experiments. It is especially useful in laboratory settings where controlled immune activation, adjuvant benchmarking, and translational vaccine research are required. For B2B buyers sourcing specialized immunology research materials, 3D-MPLA-6A offers a precise, well-defined lipid A derivative suitable for scientific procurement, laboratory development pipelines, and export-oriented bulk supply through Swasti Exports.
Key Features
| Features | Description |
|---|---|
| Product Name | 3D-MPLA-6A |
| Full Chemical Identity | 3-O-desacyl-4'-monophosphoryl lipid A, Hexa-acylated Form |
| Biological Class | Monophosphoryl Lipid A (MPLA) adjuvant |
| Source Material | Derived from Lipopolysaccharide (LPS) of Salmonella minnesota R595 |
| Molecular Structure | Hexa-acylated with six fatty acid chains |
| Primary Activity | Potent TLR4 agonist for immune activation studies |
| Research Grade | Yes |
| Attributes | Description |
|---|---|
| Product Title | 3D-MPLA-6A |
| Full Name | 3-O-desacyl-4'-monophosphoryl lipid A, Hexa-acylated Form |
| Origin | Derived from the Lipopolysaccharide (LPS) of Salmonella minnesota R595 |
| Structural Feature | Hexa-acylated |
| Fatty Acid Chains | Six |
| Biological Target | TLR4 |
| Activity Type | Agonist |
| Quality Level | Research grade |
| Application | Vaccinology, immunotherapy, and immunology research |
| Supplier | Swasti Exports |
| MOQ | 1 |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
3D-MPLA-6A is the hexa-acylated form of 3-O-desacyl-4'-monophosphoryl lipid A, which is the most bioactively potent and thoroughly characterized member of the MPLA family. Its six fatty acid chains give it a distinct structure associated with strong TLR4-mediated immune activation.
The product is derived from the lipopolysaccharide of Salmonella minnesota R595, a well-studied bacterial source used in MPLA research. This origin supports reproducibility and makes it suitable for mechanistic immune studies and adjuvant development.
It is best suited for vaccinology, immunotherapy, innate immune signaling studies, TLR4 pathway research, and evaluation of vaccine adjuvant performance in preclinical settings.
No. Based on the provided information, it is a research-grade product intended for laboratory and preclinical research use only.
TLR4 agonism is central to studying innate immune activation and downstream inflammatory signaling. 3D-MPLA-6A provides a defined molecular tool for triggering and analyzing precise immune responses in experimental systems.
Brand: chengdu gc biotech
Country Of Origin: India
Inclusive of all taxes
You Save: 0
Vadodara , India
Manufacturer, Trader, Exporter, Importer
GST- 24aixpb0733c1zo
Trust Mark
